Abstract
Objective In order to estimate the prevalence of metabolic syndrome (MetS) as defined by NCEP Adult Treatment Panel III (ATP III) criteria in the Trabzon Region and its associations with demographic factors (age, sex, marital status, reproductive history in women, and level of education), socioeconomic factors (household income and occupation), family history of selected medical conditions (diabetes, hypertension, and obesity), lifestyle factors (smoking habits, physical activity, and alcohol consumption) in the adult population. Research Methods and Procedures In this cross-sectional survey, a sample of households was systematically selected from the central province of Trabzon and its nine towns. A total of 4,809 adult subjects ≥20 years (2,601 women and 2,208 men) were included in the study. Blood pressure levels were measured for all subjects. The persons included in the questionnaire were invited to the local medical centers for blood examination between 08:00 and 10:00 following 12 h of fasting. Fasting serum glucose (FBG) levels and lipid profile were measured with autoanalyzer. MetS was defined according to guidelines from the NCEP ATP III diagnostic criteria. Results The prevalence of MetS was 26.9%: 31.3 in women and 21.7% in men. The prevalence increased with age, being highest in the 60–69-year-old age group (53.4%) but lower again in the ≥70 age group. MetS was associated positively with marital status, parity, cessation of cigarette smoking, and negatively with the level of education, alcohol consumption, current cigarette use, household income, and physical activity. Hypertension was found as the most common MetS component in our study (57.4%). Others in decreasing order were abdominal obesity (40.9%), low high-density lipoprotein-C (HDL-C) (31.8%), hypertriglyceridemia (30.7%), and high FBG levels (9.2%). Similarly, in the subjects diagnosed with MetS, HT had the highest prevalence (91.9%). This was followed by abdominal obesity (82.3%), hypertriglyceridemia (74%), low HDL-C (68.6%), and high fasting blood glucose levels (28.6%). Discussion MetS is moderately common and an important health problem in the adult population of Trabzon. In order to control MetS and its components, effective public health education and taking urgent steps are needed. These steps include serious education, providing a well-balanced diet and increasing physical activity.
Similar content being viewed by others
References
P.J. Miranda, R.A. DeFronzo, R.M. Califf, J.R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33–45 (2005)
E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991)
A. Fontbonne, Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37, 953–955 (1994)
R.L. Hanson, G. Imperatore, P.H. Bennett, W.C. Knowler, Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51, 3120–3127 (2002)
B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA. 285, 2486–2497 (2001)
S.W. Oh, Y.S. Yoon, E.S. Lee, W.K. Kim, Association between cigarette smoking and metabolic syndrome. Diabetes Care 28, 2064–2066 (2005)
Y.S. Yoon, S.W. Oh, H.W. Baik, H.S. Park, W.Y. Kim, Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 80, 217–224 (2004)
S. Yoo, T. Nicklas, T. Baranowski, I.F. Zakeri, S.J. Yang, S.R. Srinivasan, G.S. Berenson, Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: Bogalusa Heart Study. Am. J. Clin. Nutr. 80, 841–848 (2004)
C.L. Scott, Diagnosis, prevention and intervention for the metabolic syndrome. Am. J. Cardiol. 92(Suppl), 35i–42i (2003)
A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, Y.A. Kesaniemi, Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245, 163–174 (1999)
A.J. Cameron, J.E. Shaw, P.Z. Zimmet, The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. N. Am. 33, 351–375 (2004)
A. Gupta, R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta, K. Kothari, Prevalence of diabetes, impaired fasting glucose and insulin resistence syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61, 69–76 (2003)
E.S. Ford, W.H. Giles, W.H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359 (2002)
B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, J. Ticket, E. Eschwege, The D.E.S.I.R study group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29, 526–532 (2003)
A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian Adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199–204 (2003)
C. Erem, C. Arslan, A. Hacihasanoglu, O. Deger, M. Topbaş, K. Ukinc, H.Ö. Ersöz , M. Telatar, Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes. Res. 12, 1117–1127 (2004)
C. Erem, R. Yıldız, H. Kavgacı, C. Karahan, O. Değer, G. Çan, M. Telatar, Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon City). Diabetes Res. Clin. Pract. 54, 203–208 (2001)
I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, The TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25, 1551–1556 (2002)
A. Onat, K. Ceyhan, O. Basar, S. Toprak, V. Sansoy, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 165, 285–292 (2002)
A.K. Ozsahin, A. Gökcel, N. Sezgin, M. Akbaba, N. Güvener, I. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17, 230–234 (2004)
M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19, 414–418 (1996)
K. Gu Dongfeng Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He, The interASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in Chine. Lancet 365, 1398–1405 (2005)
L.N.T.D. Son, D. Kunii, N.T.K. Hung, T. Sakai, S. Yamamoto, The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res. Clin. Pract. 67, 243–250 (2005)
F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res. Clin. Pract. 61, 29–37 (2003)
V.G. Athyros, V.I. Bouloukos, A.N. Pehlivanidis, A.A. Papageorgiou, S.G. Dionysopoulou, A.N. Symeonidis, D.I. Petridis, M.I. Kapousouzi, E.A. Satsoglou, Mikhailidis DP, The MetS-Greece Collabotarive Group, The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes. Metab. 7, 397–405 (2005)
F.E.R. Punzalan, R.G. Sy, T. Ty-Willing, Prevalence of metabolic syndrome among adult Filipinos. Int. Congr. Ser. 1262, 442–445 (2004)
R. Gupta, P.C. Deedwania, A. Gupta, S. Rastogi, R.B. Panwar, K. Kothari, Prevalence of metabolic syndrome in an Indian urban population. Int. J. Cardiol. 97, 257–261 (2004)
W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, P.Z. Zimmet, Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract. 65, 143–149 (2004)
R. Miccoli, C. Bianchi, L. Odoguardi, G. Penno, F. Caricato, M.G. Giovannitti, L. Pucci, S. Del Prato, Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250–254 (2005)
H.S. Park, S.W. Oh, S.-I. Cho, W.H. Choi, Y.S. Kim, The metabolic syndrome and associated lifestyle factors among South Korean adults. Int. J. Epidemiol. 33, 328–336 (2004)
C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, V. Valles, J.M. Rios-Torres, A. Franco, G. Olaiz, J.A. Rull, J. Sepulveda, High prevalence of metabolic syndrome in Mexico. Arch. Med. Res. 35, 76–81 (2004)
J.-Y. Oh, Y.S. Hong, Y.-A. Sung, E. Barrett-Connor, Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Dibetes Care 27, 2027–2032 (2004)
WHO, Obesity: preventing and managing the global epidemic (WHO, Geneva, 1998)
J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsione, B. Schersten, C.D. Agardh, Socio-demogaphic and psychosocial factors are associated with features of the metabolic syndrome. The Women’s Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 5, 106–112 (2003)
S.P. Wamala, J. Lynch, M. Horsten, M.A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Education and the metabolic syndrome in women. Diabetes Care 22, 1999–2003 (1999)
R. Choiniere, P. Lafontaine, A.C. Edwards, Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. Can. Med. Assoc. J. 162, S13–S24 (2000)
A.M. Rissanen, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa, Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45, 419–430 (1991)
Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163, 427–436 (2003)
T.M. Tahtinen, M.J. Vanhala, J.A. Oikarinen, S.M. Keinanen-Kiukaanniemi, Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk. 5, 319–323 (1998)
S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith, Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233, 327–332 (1993)
F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven, Insulin resistance and cigarette smoking. Lancet 339, 1128–1130 (1992)
C. Kong, L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, R.S. Elkeles, Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 156, 373–378 (2002)
A.S. Leon, J. Connett, D.R. Jacobs Jr., R. Rauramaa, Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA 258, 2388–2395 (1987)
J. Pekkanen, B. Marti, A. Nissinen, J. Tuomilehto, S. Punsar, M.J. Karvonen, Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 255, 1473–1477 (1987)
P.S. Denker, V.E. Pollock, Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152, 1649–1651 (1992)
World Health Organization, The World Health Report 2000: Health System Efficiency (WHO, Geneva, 2000)
R. Ross, D. Dagnone, P.J. Jones, H. Smith, A. Paddags, R. Hudson, I. Janssen, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, cotrolled trial. Ann. Intern. Med. 133, 92–103 (2000)
Acknowledgments
This study was supported by a research grant from the Karadeniz Technical University (Project No. 2003.114.003.5).
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s12020-009-9147-5
Rights and permissions
About this article
Cite this article
Erem, C., Hacıhasanoglu, A., Deger, O. et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocr 33, 9–20 (2008). https://doi.org/10.1007/s12020-008-9044-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-008-9044-3